Skip to content

13F-HR filed by 5AM Venture Management, LLC

5AM Venture Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:02:10 UTC, with 16 holding rows worth $297,006,238.

Accession
0001799883-26-000004
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 16 entries on the cover page, a total value of $297,006,238 stated on the cover page (in dollars after the unit check, H1), rows summing to $297,006,238 with VALUE read as dollars as filed, 13F file number 028-19757. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share7,325,962$122,343,565dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock3,784,650$24,032,528dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK1,029,298$22,510,747dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM5,277,216$21,319,953dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM2,353,304$16,755,524dollars as filed
PHARVARIS NVN69605108COMMON STOCK479,900$15,222,428dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK606,660$14,129,111dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW422,270$13,685,771dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK3,947,913$10,935,719dollars as filed
BIOHAVEN LTDG1110E107COM738,972$9,865,276dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK741,893$7,559,890dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS476,200$5,204,866dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK3,057,325$4,249,682dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,369,782$4,177,835dollars as filed
EYEPOINT INC COM NEW30233G209Stock1,050,000$3,433,500dollars as filed
SKYE BIOSCIENCE INC COM83086J309Stock981,269$1,579,843dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001799883-26-000004this filing2026-11-16